medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Number 2

<< Back Next >>

Ann Hepatol 2013; 12 (2)

Focal nodular hyperplasia and hepatic regenerating nodules in pediatric oncology patients: how much invasive approach is necessary?

De Pasquale MD, Monti L, D’Andrea ML, De Ioris MA, Castellano A

Language: English
References: 22
Page: 308-314
PDF size: 643.80 Kb.


ABSTRACT

Introduction. Hepatic regenerating nodules (HRN) and focal nodular hyperplasia (FNH) are benign regenerating lesions of the liver that rarely occur in children. An increased incidence of these lesions is reported in children treated for cancer. Material and methods. Eight children who developed FNH and HRN after treatment for malignancies in the Oncology unit at the “Bambino Gesů” Pediatric Hospital in Rome, were retrospectively analyzed. Results. The lesions, considered in the differential diagnosis with metastatic relapse of the primitive disease, have been monitored with US or other available imaging techniques. Evolution of the lesions was observed in only 1 patient three years after the initial diagnosis of FNH. Conclusion. In conclusion serial monitoring with imaging techniques is sufficient to rule out liver metastasis and to monitor the evolution of the lesions. Surgery is suggested only in the case of complications.


REFERENCES

  1. Yang Y, Fu S, Li A, Zhou W, Pan Z, Cui L, Huang G, et al. Management and surgical treatment for focal nodular hyperplasia in children. Pediatr Surg Int 2008; 24: 699-703.

  2. Icher-De Bouyn C, Leclere J, Raimondo G, Le Pointe HD, Couanet D, Valteau Couanet D, Hartmann O. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Cancer 2003; 97: 3107-13.

  3. Reymond D, Plaschkes J, Lüthy AR, Leibundgut K, Hirt A, Wagner HP. Focal nodular hyperplasia of the liver in children: review of follow-up and outcome. J Pediatr Surg 1995; 30: 1590-93.

  4. Tomlinson GE, Finegold MJ. Tumors of the liver. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott; 2002, p. 847-64.

  5. Brisse H, Servois V, Bouche B, Avni F, Petit P, Thibault F, Zucker JM, et al. Hepatic regenerating nodules: a mimic of recurrent cancer in children. Pediatr Radiol 2000; 30: 386-93.

  6. Joiner BL, Levin TL, Goyal RK, Newman B, et al. Focal nodular hyperplasia of the liver: a sequel of tumor therapy. Pediatr Radiol 2005; 35: 1234-39.

  7. Takeyama J, Ando R, Sato T, Nio M, Shimanuki Y, Sato A, Imaizumi M. Focal nodular hyperplasia-like lesion of the liver in a child previously treated for nephroblastoma. Pathol Int 2008; 58: 606-8.

  8. Citak EC, Karadezeniz C, Oguz A. Nodular regenerative hyperplasia and focal nodular hyperplasia of the liver mimicking hepatic metastasis in children with solid tumors and a review of literature. Pediatr Hematol Oncol 2007; 24: 281-9.

  9. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5: 1194-200.

  10. Kumagai H, Masuda T, Oikawa H, Endo K, Endo M, Takano T. Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances. J Gastroenterol Hepatol 2000; 15: 1344-47.

  11. Towbin AJ, Lou GG, Yin H. Focal nodular hyperplasia in children, adolescent, and young adults. Pediatr Radiol 2011; 41: 341-9.

  12. Gobbi D, Dall’Igna P, Messina C, Cesca E, Cecchetto G. Focal nodular Hyperplasia in pediatric patients with or without oncologic history. Pediatr Blood Cancer 2010; 55: 1420-22.

  13. Masetti R, Biagi C, Kleinschmidt K, Prete A, Baronio F, Colecchia A, Festi D. Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? Eur J Pediatr 2011; 170: 807-12.

  14. Shamsi K, De Schepper A, Degryse H, Deckers F. Focal nodular hyperplasia of the liver: radiologic findings. Abdom Imaging 1993; 18: 32-8.

  15. Shirkhoda A, Farah MC, Bernacki E, Madrazo B, Roberts J. Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging 1994; 19: 34-8.

  16. Mortelé KJ, Praet M, Van Vlierberghe H, de Hemptinne B, Zou K, Ros PR. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 2002; 27: 700-7.

  17. Petsas T, Tsamandas A, Tsota I, Karavias D, Karatza C, Vassiliou V, Kardamakis D. A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature. World J Gastroenterol 2006; 12: 6567-71.

  18. Belghiti J, Pateron D, Panis Y, Vilgrain V, Fléiou JF, Benhamou JP, Fékété F. Resection of presumed benign liver tumours. Br J Surg 1993; 80: 380-3.

  19. Gutweiler JR, Yu DC, Kim HB, Kozakewich HP, Marcus KJ, Shamberger RC, Weldon CB. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J Pediatr Surg 2008; 43: 2297-00.

  20. Di Stasi M, Caturelli E, De Sio I, Salmi A, Buscarini E, Buscarini L. Natural history of focal nodular hyperplasia of the liver: an ultrasound study. J Clin ultrasound 1996; 24: 345-50.

  21. Okada T, Sasaki F, Kamiyama T, Nakagawa T, Nakanishi K, Onodera Y, Itoh T, et al. Management and Algorithm for focal nodular hyperplasia of the liver in children. Eur J Pediatr Surg 2006; 16: 235-40.

  22. Mathieu D, Kobeiter H, Maison P, Nakagawa T, Nakanishi K, Onodera Y, Itoh T, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000; 118: 560-4.




2020     |     www.medigraphic.com